Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes

NCT04764968 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes
Hypoglycemia

Interventions

DRUG: Dasiglucagon

Sponsor

Steno Diabetes Center Copenhagen